Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 100 of 598 entries
View as:

High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00415233 Org: User:
Start: 11/30/06 End: 07/31/25 Due: 07/31/26

Investigation of Different Relaxation Techniques in Eliciting a Relaxation Response

Phase: N/A Priority: Normal
NCT ID: NCT03592147 Org: User:
Start: 04/13/18 End: 06/04/18 Due: 06/04/19

Digital Intervention for Psychedelic Preparation (DIPP): Comparing Meditation and Music-Based Programs

Phase: N/A Priority: Normal
NCT ID: NCT06815653 Org: User:
Start: 03/31/25 End: 12/31/26 Due: 12/31/27

Native T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Rare Diseases

Phase: N/A Priority: Normal
NCT ID: NCT03199001 Org: User:
Start: 02/19/15 End: 02/19/19 Due: 02/19/20

Alcohol Consumption and Coronary Heart Disease Onset

Phase: N/A Priority: Normal
NCT ID: NCT03133689 Org: User:
Start: 03/01/17 End: 12/12/17 Due: 12/12/18

Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03430700 Org: User:
Start: 05/16/19 End: 03/17/25 Due: 03/17/26

Targeted OXYgen Therapy in Critical Illness

Phase: N/A Priority: Normal
NCT ID: NCT03287466 Org: User:
Start: 01/15/18 End: 02/15/20 Due: 02/15/21

VITAL - the Heart Failure With Reduced Ejection Fraction Sub-study

Phase: N/A Priority: Normal
NCT ID: NCT06534151 Org: User:
Start: 10/01/24 End: 12/31/28 Due: 12/31/29

Intraoperative Biomechanics in Complex Abdominal Wall Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT03296475 Org: User:
Start: 01/09/18 End: 12/01/21 Due: 12/01/22

Understanding the Role of Autoimmune Disorders on the Initial Presentation of Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT02062021 Org: User:
Start: 01/31/14 End: 06/30/15 Due: 06/30/16

EVERREST Developing a Therapy for Fetal Growth Restriction

Phase: N/A Priority: Normal
NCT ID: NCT02097667 Org: User:
Start: 03/31/14 End: 02/28/22 Due: 02/28/23

Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05635162 Org: User:
Start: 05/17/24 End: 10/31/28 Due: 10/31/29

The Use of Angiotensin Converting Enzyme Inhibitors and Incident Respiratory Infections, Are They Harmful or Protective?

Phase: N/A Priority: Normal
NCT ID: NCT04322786 Org: User:
Start: 01/01/98 End: 03/31/21 Due: 03/31/22

Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity

Phase: N/A Priority: Normal
NCT ID: NCT02183883 Org: User:
Start: 12/16/16 End: 03/22/23 Due: 03/22/24

Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)

Phase: N/A Priority: Normal
NCT ID: NCT02310997 Org: User:
Start: 07/31/11 End: 05/31/15 Due: 05/31/16

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

Phase: N/A Priority: Normal
NCT ID: NCT03474198 Org: User:
Start: 03/21/18 End: 01/20/22 Due: 01/20/23

Electrocorticographic Monitoring of Brain Retraction Injury (EMBRI)

Phase: N/A Priority: Normal
NCT ID: NCT06409806 Org: User:
Start: 08/01/22 End: 03/01/26 Due: 03/01/27

Defining Core Outcome Sets in Trigeminal Neuralgia

Phase: N/A Priority: Normal
NCT ID: NCT04272385 Org: User:
Start: 03/02/20 End: 09/30/22 Due: 09/30/23

The Deep Phenotype of Lamin A/C Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT03860454 Org: User:
Start: 03/07/19 End: 02/01/25 Due: 02/01/26

Paediatric Sjögren Syndrome Cohort Study and Repository (PaedSSCoRe)

Phase: N/A Priority: Normal
NCT ID: NCT04762108 Org: User:
Start: 01/11/20 End: 01/10/30 Due: 01/10/31

Mother and Late Preterm Lactation Study

Phase: N/A Priority: Normal
NCT ID: NCT03791749 Org: User:
Start: 01/25/19 End: 03/13/21 Due: 03/13/22

Novel MRI Assessment of Prostate Cancer VALIDATE-PRO

Phase: N/A Priority: Normal
NCT ID: NCT05017181 Org: User:
Start: 01/29/21 End: 06/01/24 Due: 06/01/25

EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03494322 Org: User:
Start: 07/20/18 End: 10/31/24 Due: 10/31/25

Pathological Changes in the Cardiovascular System in Valvular Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT06060171 Org: User:
Start: 08/01/21 End: 01/01/25 Due: 01/01/26

Ambroxol in Disease Modification in Parkinson Disease

Phase: N/A Priority: Normal
NCT ID: NCT02941822 Org: User:
Start: 12/31/16 End: 05/31/18 Due: 05/31/19